Stock screenerAll disclosures →
EDGAR →
LMAT
Conviction 24HealthcareScan · Thu, Sep 24, 2026Lemaitre Vascular Inc (LMAT) closed at $80.82 (+0.30%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 46, RS Rating 25, -31.1% from its 52-week high, +0.8% year to date. Sector: Healthcare · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
LMAT$80.82+0.30%
ResistanceSupportVol 14Insider sellVol MA14 295.83K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price80.82
Change+0.30%
Gap+0.22%
Rel volume2.83×
Avg volume287.24K
Avg $ vol23.05M
SMA 2080.21
SMA 5086.46
SMA 20094.66
Price vs 50-6.52%
Price vs 200-14.62%
MA stackbearish
50/200 cross—
Supertrenddown · 84.52
RSI (14)46
MACD hist0.57
MACD cross—
Stoch %K / %D72 / 59
ADX (14)23
+DI / −DI18 / 20
RSI divergence—
MACD divergence—
ATR %2.56%
ADR %2.13%
52w high117.39
52w low78.80
From 52w high-31.15%
Above 52w low+2.56%
New 52w highNo
SqueezeOn · 16d
Bollinger width3.79%
%B0.70
Donchian pos53.61%
Donchian high83.07
Donchian low78.22
AVWAP (52w high)92.94
vs AVWAP high-13.04%
AVWAP (52w low)80.36
vs AVWAP low+0.58%
OBV trendFlat
Chaikin MF (20)0.14
Today vs 20d2.83×
Avg vol (14d)295.82K
Avg vol (20d)287.24K
Avg $ vol (20d)23.05M
Market cap1.85B
RS Rating25 / 99
RS 3m (vs SPY)-18.45%
RS 6m (vs SPY)-44.06%
RS line new highNo
Trend template1/8
Technical rank33.1
1 week+1.70%
1 month+2.34%
3 months-13.96%
6 months-27.24%
1 year-10.07%
YTD+0.81%
P/E32.01
P/B4.40
P/S7.41
P/FCF23.57
EPS2.52
Div yield0.98%
ROE13.73%
ROA9.01%
Debt/Eq—
Current16.31
EV/EBITDA23.26
Gross margin71.53%
Net margin23.13%
Rev growth13.53%
EPS growth31.10%
Price target103.00
Target upside27.44%
Analyst ratingHold
Institutional108.08%
Ent. value1.82B
Revenue54.82M
Net income17.05M
Gross profit50.76M
Free cash flow78.41M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out22.85M
Employees655
ListedThu, Oct 19, 2006
Free float21.15M
Float %92.6%
Short interest1.52M
Days to cover4.8d
Short volume51.8%
Squeeze score61 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.74 vs $0.81
Last surprise-8.6% miss
Setup gradeD
Conviction24 / 100
Pattern quality—
Tech rank33.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance95.30
Support78.26
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- LeMaitre Vascular stock holds at USD 79.13 as valuation draws scrutinyAD HOC NEWS · Tue, Sep 22, 2026
- Understanding the Setup: (LMAT) and Scalable RiskStock Traders Daily · Tue, Sep 22, 2026
- LeMaitre Vascular (NASDAQ:LMAT) Hits New 52-Week Low - Time to Sell?MarketBeat · Mon, Sep 21, 2026
- LeMaitre Vascular stock hits 52-week low at 78.22 USD By Investing.comInvesting.com India · Mon, Sep 21, 2026
- LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from BrokeragesMarketBeat · Sun, Sep 20, 2026
Congress activity
Disclosed STOCK Act trades in LMAT
No recent disclosed trades by Congress in LMAT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LMAT
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Pellegrino Joseph P JR Director · Dividend Equivalent Rights · 2026-06-04 | Grant | 1.427 | $0 | 2026-06-04 | 2026-06-05 |
Roberts David B President and Director · Dividend Equivalent Rights · 2026-06-04 | Grant | 0.297 | $0 | 2026-06-04 | 2026-06-05 |
O'Connor John James Director · Dividend Equivalent Rights · 2026-06-04 | Grant | 0.466 | $0 | 2026-06-04 | 2026-06-05 |
LeMaitre George W Chairman and CEO · Dividend Equivalent Rights · 2026-06-04 | Grant | 11.359 | $0 | 2026-06-04 | 2026-06-05 |
Jasinski Lawrence J Director · Dividend Equivalent Rights · 2026-06-04 | Grant | 1.427 | $0 | 2026-06-04 | 2026-06-05 |
LeBlanc Dorian Paul Chief Financial Officer · Dividend Equivalent Rights · 2026-06-04 | Grant | 2.476 | $0 | 2026-06-04 | 2026-06-05 |
Roberts David B President and Director · Dividend Equivalent Rights · 2026-06-04 | Grant | 3.068 | $0 | 2026-06-04 | 2026-06-05 |
Pellegrino Joseph P JR Director · Dividend Equivalent Rights · 2026-06-04 | Grant | 3.734 | $0 | 2026-06-04 | 2026-06-05 |
LeMaitre George W Chairman and CEO · Dividend Equivalent Rights · 2026-06-04 | Grant | 16.805 | $0 | 2026-06-04 | 2026-06-05 |
LeBlanc Dorian Paul Chief Financial Officer · Dividend Equivalent Rights · 2026-06-04 | Grant | 3.152 | $0 | 2026-06-04 | 2026-06-05 |
SEC filings
EDGAR filings in LMAT · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.